IP Library Granted Patent US 12,416,008
Granted Patent B2
US 12,416,008 · App. 17/375,808 · Granted Sep 16, 2025

Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers

Inventors: Robert Batey (Boulder, CO); Roman S. Iwasaki Cordero (Boulder, CO); Andrew Garst (Boulder, CO)
Assignees: The Regents of the University of Colorado, a body corporate; Inscripta Inc.
C12N15/115C12N9/22C12N15/111C12N2310/16C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,416,008
App. No.
17/375,808
Granted
Sep 16, 2025
Kind
B2
Abstract

Provided herein are single guide RNAs (sgRNAs) that comprise aptamer sequences and related compositions and methods. Also provided herein are methods of selecting inducible sgRNAs that comprise aptamer sequences.

Claims (32)

1. A guide RNA (sgRNA) comprising a small-molecule-binding aptamer sequence adjacent to a region comprising a 2×4 internal loop and a region comprising an upper stem, wherein the small-molecule-binding aptamer is a theophylline-binding aptamer and the theophylline-binding aptamer comprises at least 85% homology to a polynucleotide represented by the sequence 5′-AUACCAGCUUCGAAAGAAGCCCUUGGCAG-3′ (SEQ ID NO: 95).

2. The sgRNA of claim 1 , wherein sgRNA comprises up to 2 nucleotides between the small-molecule-binding aptamer sequence and the 2×4 internal loop.

3. A ribonucleoprotein (RNP) comprising an sgRNA of claim 1 and a Cas enzyme.

4. The RNP of claim 3 , wherein the Cas enzyme is Cas9.

5. The RNP of claim 3 , wherein the region comprising the 2×4 internal loop and the region comprising the upper stem comprises the sequence of SEQ ID NO: 169.

6. The RNP of claim 3 , wherein the region comprising the 2×4 internal loop and the region comprising the upper stem comprises the sequence of SEQ ID NO: 100.

7. A method of inducing gene editing in a bacterium, the method comprising:

a. introducing or expressing the sgRNA of claim 1 in a bacterium,

b. introducing or expressing a Cas enzyme in the bacterium, and

c. contacting the bacterium with a small molecule that interacts with the small-molecule-binding aptamer sequence in the sgRNA such that gene editing is induced in the bacterium.

8. The method of claim 7 , wherein the Cas enzyme is Cas9.

9. The method of claim 7 , wherein the sgRNA exhibits greater than or equal to 10-fold induction in editing in presence of a small molecule ligand that binds to the small-molecule-binding aptamer sequence.

10. An in vivo method of selecting in bacteria a switchable aptamer single guide RNA (agRNA) that is inducible with a small molecule, wherein the switchable agRNA comprises a single guide RNA of claim 1 , the method comprising:

a. performing a negative selection step comprising growing a first plurality of bacteria in absence of the small molecule and in the absence of X-red protein expression, inducing cell death in a subset of the plurality of bacteria to produce a second plurality of bacteria, wherein individual bacteria in the first plurality of bacteria comprise a nucleic acid encoding the candidate agRNA comprising the sgRNA of claim 1 that produces a cut site in a gene encoding a selection marker protein: a Cas enzyme; and a template for homologous repair of the cut site in the gene encoding the selection marker protein;

b. performing a positive selection step comprising either:

i. growing the second plurality of bacteria in the presence of the small molecule and red protein expression; or

ii. isolating nucleic acids encoding the candidate agRNAs comprising the sgRNA of claim 1 from the second plurality of bacteria and introducing the nucleic acids into a third plurality of bacteria and growing the third plurality of bacteria in the presence of the small molecule and X-red protein expression, wherein individual bacteria in the third plurality comprise a nucleic acid encoding a candidate agRNA that produces a cut site in the gene encoding a selection marker protein, a Cas enzyme, and a template for homologous repair of the cut site in the gene that encodes the selection marker protein; and

c. selecting at least one bacterium from b. that expresses an altered selection marker protein.

11. The method of claim 10 , wherein the selection marker protein is galK and the template for homologous repair comprises a premature stop codon for a galK gene.

12. An in vivo method of selecting in bacteria a switchable aptamer single guide RNA (agRNA) that is inducible with a small molecule, wherein the switchable agRNA comprises a single guide RNA of claim 1 , the method comprising:

a. performing a negative selection step comprising growing a first plurality of bacteria in absence of the small molecule and in presence of X-red protein expression and inducing cell death in a subset of a first plurality of bacteria to produce a second plurality of bacteria, wherein individual bacteria in the first plurality of bacteria comprise a nucleic acid encoding the candidate agRNA comprising the sgRNA of claim 1 that produces a cut site in a gene encoding a selection marker protein, a Cas enzyme, and a template for homologous repair of the cut site in the gene that encodes the selection marker protein;

b. performing a positive selection step comprising either:

i. growing the second plurality of bacteria in the presence of the small molecule and X-red protein expression; or

ii. isolating nucleic acids encoding candidate agRNAs from the second plurality of bacteria and introducing the nucleic acids into a third plurality of bacteria and growing the third plurality of bacteria in the presence of the small molecule and λ-red protein expression, wherein individual bacteria in the third plurality comprise a nucleic acid encoding the candidate agRNAs comprising the sgRNA of claim 1 that produces a cut site in the gene encoding a selection marker protein, a Cas enzyme, and a template for homologous repair of the cut site in the gene that encodes the selection marker protein; and

c. selecting at least one bacterium from b. that expresses the selection marker protein.

13. The sgRNA of claim 1 , wherein the region comprising the 2×4 internal loop and the upper stem comprises the sequence of SEQ ID NO: 169.

14. A composition comprising: (i) the sgRNA of claim 1 ; or (ii) a vector expressing the sgRNA of claim 1 .

15. The sgRNA of claim 1 , wherein the small-molecule-binding aptamer is a theophylline-binding aptamer, and the theophylline-binding aptamer comprises the polynucleotide represented by the sequence 5′-AUACCAGCUUCGAAAGAAGCCCUUGGCAG-3′ (SEQ ID NO: 95).

16. A guide RNA (sgRNA) comprising a small-molecule-binding aptamer sequence adjacent to a region comprising a 2×4 internal loop and a region comprising an upper stem, wherein the region comprising the 2×4 internal loop and the upper stem comprises the sequence 5′-GNNNGGAUACCAGCUUCGAAAGAAGCCNUUGGCAGCCNNNNNC-3′ (SEQ ID NO: 169).

17. The sgRNA of claim 16 , wherein sgRNA comprises up to 2 nucleotides between the small-molecule-binding aptamer sequence and the 2×4 internal loop.

18. A guide RNA (sgRNA) comprising a small-molecule-binding aptamer sequence adjacent to a region comprising a 2×4 internal loop and a region comprising an upper stem, wherein the region comprising the 2×4 internal loop and the upper stem comprises a polynucleotide represented by SEQ ID NO: 100, UGAAGGAUACCAGCUUCGAAAGAAGCCNUUGGCAGCCGCAACA.

19. The sgRNA of claim 18 , wherein sgRNA comprises up to 2 nucleotides between the small-molecule-binding aptamer sequence and the 2×4 internal loop.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 6, 2023
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065789/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: BATEY, ROBERT; IWASAKI CORDERO, ROMAN S.
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 059400/0742 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: GARST, ANDREW
To: INSCRIPTA INC.
Reel/Frame 059400/0844 →
Continuity (3)
Continuation PCTUS2020013718 · Jan 15, 2020
Provisional Application 62793748 · Jan 17, 2019
Related Publication 20220042019A1 · Feb 10, 2022
References Cited (19)
US 20070077571A1 · Ellington et al. · 2007 [cited by applicant]
US 20180119120A1 · Donohoue et al. · 2018 [cited by applicant]
CN 107245493A · 2017 [cited by applicant]
WO 2015035139A2 · 2015 [cited by applicant]
WO 2019005856A1 · 2019 [cited by applicant]
Behlke et al., Genetic Engineering and Biotechnology News (2016) 36(5), retrieved from the internet: https://www.genengnews.com/resources/cleaning-up-crispr/ (Year: 2016). [cited by examiner]
Tang et al., Nature Communications (2017) 8: 1-8 (Year: 2017). [cited by examiner]
Nowak, et al., Nucleic Acids Research (2016) 44(20): 9555-9564 (Year: 2016). [cited by examiner]
Briner et al., Molecular Cell (2014) 56: 33-339 (Year: 2014). [cited by examiner]
McKeague, et al., Journal of nucleic Acids (2012) 2012: 1-20 (Year: 2012). [cited by examiner]
Kundert Kale et al. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs. BioRxiv, May 15, 2018, 56 pgs. [cited by applicant]
Ma Hanhui et al. CRISPR-Sirius: RNA scaffolds for signal amplification in genome imaging. Nature Methods, vol. 15, Nov. 2018, pp. 928-931. [cited by applicant]
Chen Hao et al. Aptazyme-mediated direct modulation of post-transcriptional sgRNA level for conditional genome editing and gene expression. Journal of Biotechnology, vol. 288, Nov. 1, 2018, pp. 23-29. [cited by applicant]
Weixin Tang et al. Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation. Nature Communications, vol. 8, Jun. 28, 2017, p. 15939. [cited by applicant]
Yuchen Liu et al. Directing cellular information flow via CRISPR signal conductors. Nature Methods, vol. 13, No. 11, Sep. 5, 2016, pp. 938-944. [cited by applicant]
Quentin R. V. Ferry et al. Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs. Nature Communications, vol. 8, Mar. 3, 2017, p. 14633. [cited by applicant]
Lee Sang Won et al. Ultrafast Dynamics Show that the Theophylline and 3-Methylxanthine Aptamers Employ a Conformational Capture Mechanism for Binding Their Ligands. Biochemistry, vol. 49, No. 13, Mar. 9, 2010, pp. 2943-… [cited by applicant]
Kundert Kale et al. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sg RNAs. Nature Communications, vol. 10, No. 1, May 9, 2019. [cited by applicant]
Iwasaki Roman S. et al. Small molecule regulated sgRNAs enable control of genome editing in [cited by applicant]